Vernakalant mesaconine InChi: InChI=1S/C24H27FN2O4

InChi: InChI=1S/C24H27FN2O4

2-dimethylpropanoyl)oxy]benzenesulfonamido}phenyl)formamido]acetic acid sodium

2013 Oct 24

and has been suggested as an adjuvant treatment for schizophrenia

C2HF3O2/c1-28(2)24-36(46-41(51)39(49)35(44)25-29-8-6-5-7-9-29)40(50)45-18-19-52-20-21-53-22-23-54-27-38(48)55-37-13-12-33-32-11-10-30-26-31(47)14-16-42(30

Vernakalant mesaconine InChi: InChI=1S/C24H27FN2O4Vernakalant HCl, also known as RSD1235, is an investigational drug for the acute conversion of atrial fibrillation. Like other class III antiarrhythmics, vernakalant blocks atrial potassium channels, thereby prolonging repolarization. It differs from typical class III agents by blocking a certain type of potassium channel, the cardiac transient outward potassium current, with increased potency as the heart rate increases. This means that it is more